Accelovance

Melbourne, Florida 32935

0 studies enrolling now · 11 studies all time

What they study most

Asthma, Bacillus Anthracis (Anthrax), Cardiovascular Disease, Diabetes, Hypertension, Influenza, Meningitis, Meningococcal, Meningococcal Vaccine, Menopause, Plague, Respiratory Syncytial Virus (RSV)

Studies at this site

• Reverse Genetic H9N2 Influenza Vaccine Study in Adults — Completed
• A Study to Evaluate the Efficacy and Safety of LCI699 Compared to Placebo in Participants With Resistant Hypertension — Completed
• A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms — Completed
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma — Completed
• A Trial to Assess the Lot Consistency, Safety, Tolerability and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Subjects Aged ≥10 to <19 Years — Completed
• Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise — Completed
• A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years — Completed
• RSV-F Vaccine and Influenza Vaccine Co-Administration Study in the Elderly — Completed
• Safety, Tolerability and Immunogenicity of Recombinant Anthrax Vaccine Compared With Anthrax Vaccine Adsorbed — Completed
• One Year Study to Evaluate Three Different Adjuvanted Doses of the Recombinant Plague Vaccine (rF1 and rV Antigens) — Completed